Evidence map›Paper›PMID 41641259›Full record

ArticleFrontiers in medicine2025

Association between

Lirong Ran, Yongjie Li, Dongwei Liao, Ziyi Chen, Guangming Wang, Yuanyuan Zhang

Abstract read
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lirong RanSchool of Clinical Medicine, Dali University, Dali, Yunnan, China.
Yongjie LiSchool of Clinical Medicine, Dali University, Dali, Yunnan, China.
Dongwei LiaoSchool of Clinical Medicine, Dali University, Dali, Yunnan, China.
Ziyi ChenSchool of Clinical Medicine, Dali University, Dali, Yunnan, China.
Guangming WangSchool of Clinical Medicine, Dali University, Dali, Yunnan, China.
Yuanyuan ZhangSchool of Clinical Medicine, Dali University, Dali, Yunnan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High altitude polycythemia (HAPC) is an important public health problem at high altitude, and genetic factors play a key role in hypoxia adaptation in Tibetan populations. The aim of this study was to investigate the association between

Indexed as

ATP6V1E2EPAS1genetic susceptibilityhigh altitude polycythemiaTibetan

Identifiers

PMID41641259
PMCPMC12865807

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.